Hepatic Macrophage STING Signaling in Liver Fibrosis: Mechanisms and Therapeutic Perspectives
Journal of Cellular Physiology · 2026
DOI: 10.1002/jcp.70235 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Cellular Physiology, 2026. Verfasst von Qiulian Lei und 3 weiteren Autor:innen. Beteiligte Einrichtung: Hospital of Chengdu, University of Traditional Chinese Medicine, Chengdu, China. Hauptthemen laut MEDLINE: Macrophages, Liver Cirrhosis, Membrane Proteins, Liver. Die Arbeit nennt 145 Literaturangaben. Gefördert von: The National Natural Science Foundation of China, Key Research and Development Project of Science and Technology Department of Sichuan Province, Key Project of Sichuan Provincial Administration of Traditional Chinese Medicine.
Abstract (Originalsprache)
Liver fibrosis (LF) arises from chronic liver injury, in which a persistently pro‐inflammatory microenvironment shaped by hepatic macrophages drives hepatic stellate cells (HSCs) activation and fibrosis progression. The cyclic GMP‐AMP synthase (cGAS)–stimulator of interferon genes (STING) pathway serves as a molecular hub linking metabolic liver injury to immune and inflammatory responses, sensing danger signals from metabolic stress, mitochondrial injury, and cell death to initiate downstream inflammatory transcription. This signaling may sustain a pro‐inflammatory macrophage phenotype and amplify inflammation, potentially driving fibrosis from reversible repair toward progressive disease. This review summarizes the pathological mechanisms and translational advances of macrophage STING signaling in LF, discusses how STING integrates mitochondrial DNA (mtDNA) sensing with non‐canonical metabolic stress signals to sustain pro‐inflammatory macrophage states via bioenergetic and organelle remodeling, and evaluates emerging therapeutic strategies aimed at modulating macrophage STING signaling, including mesenchymal stem cell (MSC)/exosome‐based approaches and natural‐product interventions, for the potential therapeutic management of LF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hospital of Chengdu, University of Traditional Chinese Medicine, Chengdu, China.
- School of Clinical Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
ORCID-Profile: Qiulian Lei
Förderung
- The National Natural Science Foundation of China
- Key Research and Development Project of Science and Technology Department of Sichuan Province
- Key Project of Sichuan Provincial Administration of Traditional Chinese Medicine
Zitieren
APA
Lei, Q., Liu, X., Yuan, Y., & Li, H. (2026). Hepatic Macrophage STING Signaling in Liver Fibrosis: Mechanisms and Therapeutic Perspectives. Journal of Cellular Physiology. https://doi.org/10.1002/jcp.70235
Vancouver
Lei Q, Liu X, Yuan Y, Li H. Hepatic Macrophage STING Signaling in Liver Fibrosis: Mechanisms and Therapeutic Perspectives. Journal of Cellular Physiology. 2026. doi:10.1002/jcp.70235
BibTeX
@article{Lei2026,
author = {Lei, Qiulian and Liu, Xinghong and Yuan, Yidan and Li, Hui},
title = {Hepatic Macrophage STING Signaling in Liver Fibrosis: Mechanisms and Therapeutic Perspectives},
journal = {Journal of Cellular Physiology},
year = {2026},
doi = {10.1002/jcp.70235}
}
EUVIMED